Table 1 Demographic and epidemiological characteristics of COVID-19 cases
From: Propagation of a hospital-associated cluster of COVID-19 in Malaysia
| Â | Overall | Cases | ||
|---|---|---|---|---|
| Â | Healthcare workers | Patients | Community | |
Count, n | 34 | 10 | 9 | 15 |
Age* in years, median [IQR] | 42.0 [29.0, 80.8] | 31.0 [28.0, 37.0] | 80.0 [74.0, 81.0] | 36.0 [28.5, 85.0] |
Age* more than 60Â years (%) | 15 (44.1) | 0 (0.0) | 9 (100.0) | 6 (40.0) |
Female (%) | 25 (73.5) | 8 (80.0) | 6 (66.7) | 11 (73.3) |
Symptomatic (%) | 28 (82.4) | 10 (100.0) | 7 (77.8) | 11 (73.3) |
 Fever | 17 (50.0) | 6 (60.0) | 5 (55.6) | 6 (40.0) |
 Cough | 16 (47.1) | 5 (50.0) | 4 (44.4) | 7 (46.7) |
 Sore throat* | 10 (29.4) | 7 (70.0) | 1 (11.1) | 2 (13.3) |
 Coryza | 4 (11.8) | 3 (30.0) | – | 1 (6.7) |
 Anosmia | 3 (8.8) | 3 (30.0) | – | – |
 Dyspnoea | 3 (8.8) | 1 (10.0) | 1 (11.1) | 1 (6.7) |
 Gastrointestinal symptoms | 4 (11.8) | – | 3 (33.3) | 1 (6.7) |
 Lethargy | 1 (2.9) | – | – | 1 (6.7) |
Previous comorbidities* (%) | 19 (55.9) | 3 (30.0) | 9 (100.0) | 7 (46.7) |
 Diabetes mellitus | 12 (35.3) | – | 7 (77.8) | 5 (33.3) |
 Hypertension | 10 (29.4) | – | 5 (55.6) | 5 (33.3) |
 Cardiovascular disease | 6 (17.6) | – | 5 (55.6) | 1 (6.7) |
 Hyperlipidaemia | 6 (17.6) | – | 6 (66.7) | – |
 Chronic kidney disease | 4 (11.8) | – | 3 (33.3) | 1 (6.7) |
 History of cancer | 2 (5.9) | 1 (10.0) | – | 1 (6.7) |
 Other comorbidities | 14 (41.2) | 2 (20.0) | 7 (77.8) | 5 (33.3) |
Duration (in days), median [IQR] | ||||
 Symptom onset to diagnosis | 2.0 [1.0, 5.0] | 3.0 [2.0, 6.0] | 1.0 [0.0, 2.0] | 1.0 [0.0, 3.5] |
 Symptom onset to admission to hospital | 2.0 [1.0, 4.0] | 4.0 [2.0, 7.0] | 1.0 [0.0, 2.0] | 2.0 [0.0, 4.0] |
 Diagnosis to admission to hospital | 0.0 [0.0, 1.0] | 1.0 [0.0, 1.0] | 0.0 [0.0, 0.0] | 0.0 [0.0, 1.0] |
 Admission to discharge (n = 29) | 20.0 [14.0, 32.0] | 16.0 [9.0, 25.0] | 33.0 [33.0, 39.0] | 18.0 [11.0, 24.0] |